Cat. No. 4725
Biological ActivityGlycoprotein (GP) IIb/IIIa inhibitor. Reversibly and competitively binds to GPIIa/IIIb on platelets, inhibiting aggregation.
(Modifications: X1 = Mpa, X2 = Har, Disulfide bridge: 1-7, Cys-7 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
O'Shea and Tcheng (2002) Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa. Expert Opin.Pharmacother. 3 1199. PMID: 12150697.
If you know of a relevant reference for Eptifibatide please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Eptifibatide from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Eptifibatide, supplier, Glycoprotein, GP, IIb/IIIa, inhibitors, inhibits, platelets, aggregation, antiplatelet, Tocris Bioscience, Integrin Inhibitor products
Find multiple products by catalog number
New Products in this Area
Toll-like receptor (TLR) 5/Flagellin complex antagonistBioymifi
DR5 (TRAIL receptor) agonist; induces apoptosisBOP
Dual α9β/1α4β1 integrin inhibitor; preferentially mobilizes HSCs
September 27 - 30, 2017